KwdFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « KwdFr.i » - entrée « Lupus érythémateux disséminé (traitement médicamenteux) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Lupus érythémateux disséminé (sang) < Lupus érythémateux disséminé (traitement médicamenteux) < Lupus érythémateux disséminé (étiologie)  Facettes :

List of bibliographic references indexed by Lupus érythémateux disséminé (traitement médicamenteux)

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000B34 (2019) Sibel Balci [Turquie] ; Rabia Miray Kisla Ekinci [Turquie] ; Aysun Karabay Bayazit [Turquie] ; Engin Melek [Turquie] ; Dilek Dogruel [Turquie] ; Derya Ufuk Altintas [Turquie] ; Mustafa Yilmaz [Turquie]Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.
001673 (2017) Atsuko Iwai [Japon] ; Taio Naniwa [Japon] ; Shinya Tamechika [Japon] ; Shinji Maeda [Japon]Short-term add-on tocilizumab and intravenous cyclophosphamide exhibited a remission-inducing effect in a patient with systemic lupus erythematosus with refractory multiorgan involvements including massive pericarditis and glomerulonephritis.
001694 (2017) Laurie S. Davis ; Andreas M. ReimoldResearch and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
001936 (2017) C. Kneitz [Allemagne] ; J. Atta [Allemagne] ; H. Burkhardt [Allemagne]
001A42 (2016) Pietro Enea Lazzerini ; Pier Leopoldo Capecchi ; Giacomo Maria Guidelli ; Enrico Selvi ; Maurizio Acampa [Italie] ; Franco Laghi-PasiniSpotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date.
001C86 (2016) Özgül Mu Tu Koryürek ; Göknur Kalkan [Turquie]A new alternative therapy in dermatology: tocilizumab.
001E85 (2015) M. Ollé [Espagne]The European League Against Rheumatism (EULAR) - 16th Annual European Congress (June 10-13, 2015 - Rome, Italy).
001F12 (2015) Martin Aringer [Allemagne] ; Josef S. SmolenSafety of off-label biologicals in systemic lupus erythematosus.
002342 (2014) M. Jüptner [Allemagne] ; R. Zeuner ; S. Schreiber ; M. Laudes ; J O SchröderSuccessful application of belimumab in two patients with systemic lupus erythematosus experiencing a flare during tocilizumab treatment.
002346 (2014) Uma Thanarajasingam [États-Unis] ; Timothy B. NiewoldSirukumab : a novel therapy for lupus nephritis?
002664 (2013) Rieke Alten [Allemagne] ; Tazio MaleitzkeTocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases.
002757 (2013) Sabine Adler ; Mirjam Kolev ; Pierre-Alain Varisco ; Manuela Tham ; Michael Von Gunten ; Christoph Tappeiner ; Peter M. VilligerInduction of severe systemic lupus erythematosus by TNF blockade and response to anti-IL-6 strategy.
002865 (2013) Yuko Shirota [États-Unis] ; Cheryl Yarboro [États-Unis] ; Randy Fischer [États-Unis] ; Tuyet-Hang Pham [États-Unis] ; Peter Lipsky [États-Unis] ; Gabor G. Illei [États-Unis]Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus
003454 (2012) K. Maeshima [Japon] ; K. Ishii ; M. Torigoe ; C. Imada ; M. Iwakura ; H. Hamasaki ; M. Akamine ; M. Haranaka ; H. YoshimatsuSuccessful tocilizumab and tacrolimus treatment in a patient with rheumatoid arthritis complicated by systemic lupus erythematosus.
003900 (2011) Xavier Mariette [France] ; Jacques-Eric Gottenberg ; Philippe Ravaud ; Bernard CombeRegistries in rheumatoid arthritis and autoimmune diseases: data from the French registries.
003923 (2011) Robert S. Woodrick [États-Unis] ; Eric M. RudermanInterleukin 6 inhibition - RA and beyond.
003A72 (2011) Kjell Tullus [Royaume-Uni]New developments in the treatment of systemic lupus erythematosus
003E65 (2010) Gabor G. Illei [États-Unis] ; Yuko Shirota [États-Unis] ; Cheryl H. Yarboro [États-Unis] ; Jimmy Daruwalla [États-Unis] ; Edward Tackey [États-Unis] ; Kazuki Takada [États-Unis] ; Thomas Fleisher [États-Unis] ; James E. Balow [États-Unis] ; Peter E. Lipsky [États-Unis]Tocilizumab in Systemic Lupus Erythematosus: Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
004228 (2006) Changhai Ding [Australie] ; Graeme JonesAnti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Lupus érythémateux disséminé (traitement médicamenteux)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Lupus érythémateux disséminé (traitement médicamenteux)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Lupus érythémateux disséminé (traitement médicamenteux)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021